Residual diseases after conization of women with stage IA–IB1 cervical carcinoma in region with high incidence
✍ Scribed by Chatchotikawong, U.; Ruengkhachorn, I.
- Book ID
- 127246070
- Publisher
- Elsevier Science
- Year
- 2014
- Tongue
- English
- Weight
- 44 KB
- Volume
- 133
- Category
- Article
- ISSN
- 0090-8258
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## BACKGROUND The authors evaluated clinical and pathologic factors that predicted for recurrence after patients underwent radical surgery for International Federation of Gynecology and Obstetrics (FIGO) Stage IA~2~–IB~1–2~ cervical carcinoma and developed a simple method of scoring th
## Abstract ## BACKGROUND The evaluation of residual disease (RD) after chemoradiation therapy (CRT) in stage IB2/II cervical carcinoma conventionally is based on a clinical examination and magnetic resonance imaging (MRI) performed 3 to 8 weeks after the end of treatment. Very few studies have co